Shawn A. Scranton
President at Amber Ophthalmics
Profile
Shawn A.
Scranton is currently the President & Chief Scientific Officer at Amber Ophthalmics.
Previously, he held positions as Vice President-Scientific Operations at Victory Pharma, Inc. from 2007 to 2012, Chief Scientific Officer & Senior Vice President at Sentynl Therapeutics, Inc. from 2015 to 2017, and Chief Operating Officer & Senior Vice President at Pfenex, Inc. from 2018 to 2020.
Prior to these roles, he worked as Director-Translational Medicine at Kalypsys, Inc. from 2005 to 2007, Director-Clinical Research & Program at Salmedix, Inc. from 2001 to 2005, and Principal at Dura Pharmaceuticals, Inc. from 1998 to 2000.
He also served as a Faculty Member at Baylor College of Medicine.
Scranton received his undergraduate degree from the University of California San Diego in 1988 and his doctorate from the University of the Pacific in 1994.
Shawn A. Scranton active positions
Companies | Position | Start |
---|---|---|
Amber Ophthalmics
Amber Ophthalmics BiotechnologyHealth Technology Amber Ophthalmics is a clinical-stage biotechnology company that focuses on ophthalmology. The company is based in San Diego, CA. The company has developed a patent-protected, first-in-class unmodified antisense oligonucleotide that inhibits a cell membrane hemichannel forming protein called connexin43 (cx43). | President | - |
Former positions of Shawn A. Scranton
Companies | Position | End |
---|---|---|
PFENEX INC. | Chief Operating Officer | 30/09/2020 |
Sentynl Therapeutics, Inc.
Sentynl Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Sentynl Therapeutics, Inc. acquires, develops and commercializes prescription products. The company was founded by Matthew Heck and is headquartered in Solana Beach, CA. | Chief Tech/Sci/R&D Officer | 31/12/2016 |
Victory Pharma, Inc.
Victory Pharma, Inc. Pharmaceuticals: MajorHealth Technology Victory Pharma, Inc. was a specialty pharmaceutical company that acquired markets and developed prescription pharmaceutical products that treat pain and related conditions. It marketed these products to health care professionals through its experienced U.S. commercial organization. The company was founded in 2003 and was headquartered in San Diego, CA. | Chief Tech/Sci/R&D Officer | 01/01/2012 |
Kalypsys, Inc.
Kalypsys, Inc. Pharmaceuticals: MajorHealth Technology Kalypsys, Inc. discovered and developed novel, first-in-class therapeutic agents to address unmet medical needs in respiratory and inflammatory diseases. The firm advanced its proprietary lead program, a novel, non-corticosteroid small molecule formulated for intranasal delivery, into clinical proof of concept studies. The company was founded by Pratik Shah, Jeremy S. Caldwell, Randall W. King, Kevin D. Lustig, Peter G. Schultz and Robert Downs in 2001 and was headquartered in Solana Beach, CA. | Corporate Officer/Principal | 01/01/2007 |
Salmedix, Inc.
Salmedix, Inc. Pharmaceuticals: MajorHealth Technology Salmedix, Inc. develops oncology and small molecule drugs to treat hematological malignancies. The company's product, Treanda, is currently in Phase II clinical trials in the United States and Canada for the treatment of indolent (slowly progressing) non-Hodgkin's lymphoma. It was founded in 2000 and is located in San Diego, CA. | Corporate Officer/Principal | 01/01/2005 |
Training of Shawn A. Scranton
University of California San Diego | Undergraduate Degree |
University of the Pacific | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 7 |
---|---|
Dura Pharmaceuticals, Inc.
Dura Pharmaceuticals, Inc. BiotechnologyHealth Technology Dura Pharmaceuticals, Inc. markets and sells prescription products that treat infectious and respiratory diseases. Dura focuses on products and transactions that leverage its sales and marketing organization. Dura also intends, through the use of collaborative relationships, to develop the Spiros® motorized blisterdisk and Spiros® S2 pulmonary drug delivery systems for the local and systemic delivery of a wide range of medications. It is located in San Diego, CA. | Health Technology |
Kalypsys, Inc.
Kalypsys, Inc. Pharmaceuticals: MajorHealth Technology Kalypsys, Inc. discovered and developed novel, first-in-class therapeutic agents to address unmet medical needs in respiratory and inflammatory diseases. The firm advanced its proprietary lead program, a novel, non-corticosteroid small molecule formulated for intranasal delivery, into clinical proof of concept studies. The company was founded by Pratik Shah, Jeremy S. Caldwell, Randall W. King, Kevin D. Lustig, Peter G. Schultz and Robert Downs in 2001 and was headquartered in Solana Beach, CA. | Health Technology |
Salmedix, Inc.
Salmedix, Inc. Pharmaceuticals: MajorHealth Technology Salmedix, Inc. develops oncology and small molecule drugs to treat hematological malignancies. The company's product, Treanda, is currently in Phase II clinical trials in the United States and Canada for the treatment of indolent (slowly progressing) non-Hodgkin's lymphoma. It was founded in 2000 and is located in San Diego, CA. | Health Technology |
Victory Pharma, Inc.
Victory Pharma, Inc. Pharmaceuticals: MajorHealth Technology Victory Pharma, Inc. was a specialty pharmaceutical company that acquired markets and developed prescription pharmaceutical products that treat pain and related conditions. It marketed these products to health care professionals through its experienced U.S. commercial organization. The company was founded in 2003 and was headquartered in San Diego, CA. | Health Technology |
Pelican Inc
Pelican Inc BiotechnologyHealth Technology Pfenex, Inc. is a development and licensing Biotechnology Company, which focuses on leveraging its Pfenex Expression Technology platform for developing and improving protein therapies. Its products include PF708, PF743, PF745, CRM197, PF810, PF753 and PFXX. The company was founded on November 19, 2009 and is headquartered in San Diego, CA. | Health Technology |
Sentynl Therapeutics, Inc.
Sentynl Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Sentynl Therapeutics, Inc. acquires, develops and commercializes prescription products. The company was founded by Matthew Heck and is headquartered in Solana Beach, CA. | Health Technology |
Amber Ophthalmics
Amber Ophthalmics BiotechnologyHealth Technology Amber Ophthalmics is a clinical-stage biotechnology company that focuses on ophthalmology. The company is based in San Diego, CA. The company has developed a patent-protected, first-in-class unmodified antisense oligonucleotide that inhibits a cell membrane hemichannel forming protein called connexin43 (cx43). | Health Technology |
- Stock Market
- Insiders
- Shawn A. Scranton